tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RPRX Stock Latest News

Royalty Pharma Declares Second Quarter 2024 Dividend
Press ReleasesRoyalty Pharma Declares Second Quarter 2024 Dividend
2d ago
RPRX
Royalty Pharma price target lowered to $38 from $40 at BofA
PremiumThe Fly
Royalty Pharma price target lowered to $38 from $40 at BofA
7d ago
RPRX
Ionis Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
1M ago
IONS
RPRX
TipRanks’‘Perfect 10’ List: These 2 Biotech Stocks Look Compelling at Current Levels
PremiumStock Analysis & Ideas
TipRanks’‘Perfect 10’ List: These 2 Biotech Stocks Look Compelling at Current Levels
2M ago
CLDX
RPRX
Royalty Pharma Reports Q4 and Full Year 2023 Results
PremiumPress Releases
Royalty Pharma Reports Q4 and Full Year 2023 Results
2M ago
RPRX
Royalty Pharma reports Q4 revenue $596M, consensus $691.65M
PremiumThe FlyRoyalty Pharma reports Q4 revenue $596M, consensus $691.65M
2M ago
RPRX
Royalty Pharma Backs MorphoSys’s Acquisition with Strategic Investment
PremiumCompany Announcements
Royalty Pharma Backs MorphoSys’s Acquisition with Strategic Investment
2M ago
8K
RPRX
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
PremiumPress Releases
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
3M ago
RPRX
Royalty Pharma Announces Dividend Increase
PremiumPress Releases
Royalty Pharma Announces Dividend Increase
3M ago
RPRX
Royalty Pharma increases quarterly dividend 5% to 21c per share
PremiumThe Fly
Royalty Pharma increases quarterly dividend 5% to 21c per share
3M ago
RPRX
Royalty Pharma sees 2023 Porfolio Receipts of $3.05B
PremiumThe Fly
Royalty Pharma sees 2023 Porfolio Receipts of $3.05B
3M ago
RPRX
Royalty Pharma director sells $13.2M in common stock as part of option exercise
PremiumThe Fly
Royalty Pharma director sells $13.2M in common stock as part of option exercise
4M ago
RPRX
Royalty Pharma price target lowered by $11 at Morgan Stanley, here’s why
PremiumThe FlyRoyalty Pharma price target lowered by $11 at Morgan Stanley, here’s why
4M ago
RPRX
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
PremiumPress Releases
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
5M ago
RPRX
Royalty Pharma to fund up to $125M for LAI Program in collaboration with Teva
PremiumThe Fly
Royalty Pharma to fund up to $125M for LAI Program in collaboration with Teva
5M ago
RPRX
TEVA
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
PremiumPress Releases
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
5M ago
RPRX
Royalty Pharma Q3 revenue $536M, consensus $614.36M
PremiumThe Fly
Royalty Pharma Q3 revenue $536M, consensus $614.36M
5M ago
RPRX
Royalty Pharma Reports Third Quarter 2023 Results
PremiumPress Releases
Royalty Pharma Reports Third Quarter 2023 Results
5M ago
RPRX
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
PremiumPress Releases
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
6M ago
RPRX
PTC Therapeutics signs royalty agreement with Royalty Pharma for Evrysdi
PremiumThe FlyPTC Therapeutics signs royalty agreement with Royalty Pharma for Evrysdi
6M ago
PTCT
RPRX
Royalty Pharma Declares Fourth Quarter 2023 Dividend
PremiumPress Releases
Royalty Pharma Declares Fourth Quarter 2023 Dividend
6M ago
RPRX
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
PremiumPress Releases
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
6M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >